Surgery remains the standard of care for solid tumor cancers. Sunil Singhal, MD, a general thoracic surgeon and researcher at Penn Medicine, outlines his innovative approach to addressing tumor recurrence, which is common in one third of patients: Intraoperative, fluorescent-guided surgery.
"For the first time, we have almost an extra sense in the operating room. Something that is going to enhance our ability to see tumors—the margins, the edges and the lymph nodes."
Dr. Singhal has championed intraoperative, fluorescent-guided imaging across multiple subspecialties at Penn Medicine. Details about how surgeons at Penn Medicine are implementing TumorGlow™ technology to prevent cancer recurrence can be found in the clinical briefing, "Intraoperative Molecular Imaging Detects Residual Tumor Cells During Lung Cancer Surgery."
Related Links:
Clinical Brief: Intraoperative Molecular Imaging Detects Residual Tumor Cells During Lung Cancer Surgery
Podcast: The Science of Making Tumors Glow: Innovations from the Center for Precision Surgery
Dr. Singhal’s Profile
Published
March 6, 2019
Created by
BROADCASTMED